RxRevu
Denver, US · Founded 2013 · Delaware corporation
Founders & leadership
RxRevu was founded in 2013 by David Carmody Huntress.
DC
David Carmody HuntressFounder
DC
Daniel CaronExecutive
KO
Kevin O'BrienNamed on SEC filing
Board
JP
Jeffrey PattonBoard director
SL
Steve LindsethBoard director
Funding
SEC filings, press & company announcements$22.6M disclosed across 4 rounds · 2014–2022
- Undisclosed amountSeries BJan 2021Source ↗
▶$6MraisedJan 2023 · 1 investors · Other Health CareRule 506(b)
▶$6MraisedJan 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen McHaleDirector
- Kyle KiserExecutive Officer, Director
- Andrew FirlikDirector
- Steve LindsethExecutive Officer, Director
- Christie CallahanExecutive Officer
- Toby CosgroveDirector
- Albert PrastDirector
- Benton BarneyExecutive Officer
- Richard ZaneDirector
- Aaron CornellExecutive Officer
- Daniel GallesDirector
- Lew ParkerExecutive Officer
- Offering amount
- $10M
- Amount sold
- $6M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedJul 2021 · 1 investors · Other Health CareRule 506(b)
▶$8MraisedJul 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stephen McHaleDirector
- Albert PrastDirector
- Andrew FirlikDirector
- Aaron CornellExecutive Officer
- Toby CosgroveDirector
- Kyle KiserExecutive Officer, Director
- Daniel GallesDirector
- Steve LindsethExecutive Officer, Director
- Richard ZaneDirector
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.7MraisedJan 2017 · 44 investors · Other Health CareRule 506(b)
▶$4.7MraisedJan 2017 · 44 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin O'BrienExecutive Officer, Director
- Daniel CaronExecutive Officer
- Steve LindsethDirector
- David Carmody HuntressExecutive Officer, Director
- Jeffrey PattonDirector
- Offering amount
- $5.4M
- Amount sold
- $4.7M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$3.8MraisedOct 2016 · 44 investors · Other Health CareRule 506(b)
▶$3.8MraisedOct 2016 · 44 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey PattonDirector
- David Carmody HuntressExecutive Officer, Director
- Kevin O'BrienExecutive Officer, Director
- Steve LindsethDirector
- Daniel CaronExecutive Officer
- Offering amount
- $4.5M
- Amount sold
- $3.8M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $149.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded RxRevu?
- RxRevu was founded by David Carmody Huntress in 2013.
- How much funding has RxRevu raised?
- RxRevu has disclosed $22.6M raised across 4 rounds.
- Where is RxRevu headquartered?
- RxRevu is headquartered in Denver, US.